Waldencast Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify businesses in the beauty, personal care, and wellness sectors. The company was incorporated in 2020 and is based in White Plains, New York.
IPO Year: 2021
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/25/2024 | $5.00 | Buy | Canaccord Genuity |
| 5/1/2024 | $10.00 → $8.00 | Outperform | Telsey Advisory Group |
| 7/24/2023 | Outperform → Mkt Perform | Raymond James | |
| 9/9/2022 | $12.00 | Buy | DA Davidson |
| 8/22/2022 | $11.00 | Outperform | Raymond James |
| 8/17/2022 | $11.00 | Buy | Jefferies |
| 7/19/2022 | $13.00 | Outperform | Telsey Advisory Group |
6-K - Waldencast plc (0001840199) (Filer)
6-K - Waldencast plc (0001840199) (Filer)
20-F/A - Waldencast plc (0001840199) (Filer)
6-K - Waldencast plc (0001840199) (Filer)
6-K - Waldencast plc (0001840199) (Filer)
6-K - Waldencast plc (0001840199) (Filer)
6-K - Waldencast plc (0001840199) (Filer)
6-K - Waldencast plc (0001840199) (Filer)
6-K - Waldencast plc (0001840199) (Filer)
424B3 - Waldencast plc (0001840199) (Filer)
NEW YORK, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast" or "the Company"), a global multi-brand beauty and wellness platform, today announced the formation of a new Creative Council. The interdisciplinary team of industry disruptors will come together to help Waldencast stay ahead of the curve by ideating on long-term macro and micro-trends in the beauty and wellness industry, and to ensure the Company evolves to meet customer needs now and in the future. The Creative Council will focus on what is next in beauty, wellness, and culture. The goal of the powerhouse group is to provide a pulse on trends and become the dreamers and makers of what these industrie
LONG BEACH, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Obagi Cosmeceuticals LLC ("Obagi"), a leader in skincare innovation and the originator of medical-grade skincare, is thrilled to announce the appointment of Dr. Suzan Obagi as the Company's first-ever Chief Medical Director. Obagi is a subsidiary of Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform and publicly listed company. Dr. Obagi brings a wealth of experience and expertise to her role, further solidifying Obagi's commitment to providing advanced, transformative skincare solutions. Dr. Suzan Obagi is a world-renowned, leading board-certified dermatologist and cosmetic surgeon, recogni
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Waldencast plc (NASDAQ:WALD) investors that a lawsuit was filed on behalf of investors that purchased Waldencast securities. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. Waldencast revealed on January 31, 2024, that Philippe Gau
NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast" or "the Company"), a global multi-brand beauty and wellness platform, announced today that Manuel Manfredi will join the Company as Chief Financial Officer on April 1, 2024. Philippe Gautier, currently Chief Financial Officer and Chief Operating Officer is leaving the Company, effective today. Michel Brousset, Founder and Chief Executive Officer of the Company who had previously assumed the combined roles of Chief Executive Officer and Chief Financial Officer prior to the appointment of Mr. Gautier, will serve as the Company's interim Chief Financial Officer through March 31, 2024. Manuel Manfredi
$70.2 million of Net Revenue Q3 2024+34.6% Comparable Net Revenue GrowthBoth brands accelerating from Q2 2024+45.5% Obagi Medical and +23.5% Milk Makeup vs Q3 2023Adjusted EBITDA of $11.4 million, up +134.0% vs Q3 2023 LONDON, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended September 30, 2024 ("Q3 2024") and nine months ended September 30, 2024 ("Nine Months 2024") on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company's investor relations site at http://ir.waldencast.com/. Michel Brouss
LONDON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform provided the details for its Third Quarter Fiscal 2024 conference call and webcast. As previously announced, the Company will issue its Third Quarter Fiscal 2024 results on November 20, 2024 after the close of the U.S. market. Management will host a conference call to discuss its Third Quarter Fiscal 2024 results on November 21, 2024 at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call will be webcast live and include
$63.3 million of Net Revenue Q2 2024 +25.7% net revenue Comparable Growth: +30.9% Obagi Medical and +20.0% Milk Makeup vs Q2 2023 Adjusted EBITDA of $6.3 million, up +64.5% vs Q2 2023 NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended June 30, 2024 ("Q2 2024") and six months ended June 30, 2024 ("H1 2024") on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company's investor relations site at http://ir.waldencast.com/. Michel Brousset, Waldencast Founder and CEO, said: "We
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, provided second quarter and first half fiscal 2024 earnings conference call and webcast information. As previously announced, the Company will report second quarter and first half fiscal 2024 earnings on August 27th, after the close of the U.S. stock market. The Company will conduct a conference call to discuss its earnings results on Wednesday, August 28, 2024 at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call wi
WHITE PLAINS, N.Y., June 27, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast dates. On Tuesday, August 27, 2024, after the U.S. stock market closes, the Company plans to issue a press release detailing its financial performance for the second quarter and first half of fiscal 2024. The Company's management team will conduct a conference call and webcast with slide presentation to discuss its results, strategy and outlook on Wednesday, August 28, 2024 at 8:30am ET. On Wednesday, November 20, 2024, after the U.S. stock market closes, the Company plans to
$68.3 million of Net Revenue+21.0% Comparable Net Revenue: +20.6% Obagi Skincare and +21.5% Milk MakeupAdjusted EBITDA of $11.4 million, up +12.9% vs Q1 2023 WHITE PLAINS, N.Y., May 21, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the quarter ended March 31, 2024 ("Q1 2024 Financials") on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company's investor relations site at http://ir.waldencast.com/. Michel Brousset, Waldencast Founder and CEO, said: "We had a strong start to the year, growing 21.0% in Comparable Net Rev
NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, announced that it will release its first quarter fiscal 2024 earnings results before the U.S. stock market opens on Tuesday, May 21, 2024. The Company will conduct a conference call to discuss its earnings results on the same day at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call will be webcast live and can be accessed at https://ir.waldencast.com/. A replay of the webcast will remain available on the website for 90
— H1'23 Total Net Revenue of $109.3 million— H1'23 Combined Adjusted EBITDA of $13.9 million up from $7.6 million in H1'22— Introduces guidance WHITE PLAINS, N.Y., March 20, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today announced that it furnished its results for the interim period ended June 30, 2023 ("H1 2023 Interim Financials") on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company's investor relations site at http://ir.waldencast.com/. Michel Brousset, Waldencast Founder and CEO, said: "2023 was a year of transition during which we acc
Acquisition to Accelerate Strategic Growth in a Key Skincare Market Company Moves Fourth Quarter Fiscal 2022 Earnings Call to April 26, 2023 NEW YORK, March 13, 2023 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, announced today that it signed a binding letter of intent to acquire a 60% controlling interest in a newly formed entity to be comprised of the business of its Southeast Asia (SEA) distributor. The letter of intent is binding upon the SEA distributor, but Waldencast's obligations are subject to the satisfaction of certain conditions. Assuming the satisfactory completion of its due diligence and negotiation of
NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, today announced that it will hold a conference call to discuss its fourth quarter 2022 earnings results on Wednesday, March 15, 2023 at 8:30am ET. The fourth quarter 2022 earnings press release will be issued prior to the start of the call. Investors and analysts interested in participating in the conference call are invited to dial (833) 630-1956 or (412) 317-1837 for a toll-free number. The conference call will be webcast live and can be accessed at https://ir.waldencast.com/. A replay of the webcast will remain available on the website for 90 day
4 - Waldencast Acquisition Corp. (0001840199) (Issuer)
3 - Waldencast Acquisition Corp. (0001840199) (Issuer)
3 - Waldencast Acquisition Corp. (0001840199) (Issuer)
$70.2 million of Net Revenue Q3 2024+34.6% Comparable Net Revenue GrowthBoth brands accelerating from Q2 2024+45.5% Obagi Medical and +23.5% Milk Makeup vs Q3 2023Adjusted EBITDA of $11.4 million, up +134.0% vs Q3 2023 LONDON, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended September 30, 2024 ("Q3 2024") and nine months ended September 30, 2024 ("Nine Months 2024") on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company's investor relations site at http://ir.waldencast.com/. Michel Brouss
LONDON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform provided the details for its Third Quarter Fiscal 2024 conference call and webcast. As previously announced, the Company will issue its Third Quarter Fiscal 2024 results on November 20, 2024 after the close of the U.S. market. Management will host a conference call to discuss its Third Quarter Fiscal 2024 results on November 21, 2024 at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call will be webcast live and include
NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, announced today that Hind Sebti, Kelly Brookie and Roberto Thompson have been appointed to its board of Directors (the "Board"), effective September 26, 2024. These executives bring extensive professional experience further enhancing the breadth of talent and expertise possessed by the Board. Ms. Brookie will replace Sarah Brown who has informed the Board of her intention to not renew her mandate ahead of the Company's Annual General Meeting. The Company also announced that its Annual General Meeting is scheduled for October 28, 2024 d
NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Obagi Medical ("Obagi"), a leader in advanced skincare innovation and pioneer in medical-grade skincare and a subsidiary of Waldencast plc, (NASDAQ:WALD) ("Waldencast"), proudly announces the launch of two groundbreaking skincare products: ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate. Both products deliver transformative results, leveraging cutting-edge technology and advanced formulations to enhance skin appearance and texture. The ELASTIDERM® Lift Up & Sculpt Facial Moisturizer is clinically proven to visibly lift and sculpt facial contours. This advanced moisturizer actively supports skin's
$63.3 million of Net Revenue Q2 2024 +25.7% net revenue Comparable Growth: +30.9% Obagi Medical and +20.0% Milk Makeup vs Q2 2023 Adjusted EBITDA of $6.3 million, up +64.5% vs Q2 2023 NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended June 30, 2024 ("Q2 2024") and six months ended June 30, 2024 ("H1 2024") on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company's investor relations site at http://ir.waldencast.com/. Michel Brousset, Waldencast Founder and CEO, said: "We
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, provided second quarter and first half fiscal 2024 earnings conference call and webcast information. As previously announced, the Company will report second quarter and first half fiscal 2024 earnings on August 27th, after the close of the U.S. stock market. The Company will conduct a conference call to discuss its earnings results on Wednesday, August 28, 2024 at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call wi
WHITE PLAINS, N.Y., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today announced that the Company will participate in the Canaccord Genuity 44th Annual Growth Conference being held at the InterContinental Boston Hotel in Boston, Massachusetts. Michel Brousset, Founder and Chief Executive Officer, will participate in a fireside chat presentation on Wednesday, August 14, 2024 at 12:30 p.m. Eastern Standard Time and host meetings with investors throughout the day. The fireside chat presentation will be available live and for replay on the Investor Relations page on the company's website at w
WHITE PLAINS, N.Y., June 27, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast dates. On Tuesday, August 27, 2024, after the U.S. stock market closes, the Company plans to issue a press release detailing its financial performance for the second quarter and first half of fiscal 2024. The Company's management team will conduct a conference call and webcast with slide presentation to discuss its results, strategy and outlook on Wednesday, August 28, 2024 at 8:30am ET. On Wednesday, November 20, 2024, after the U.S. stock market closes, the Company plans to
WHITE PLAINS, N.Y., May 30, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today announced that the Company will participate in upcoming investor conferences. On June 5, 2024, the Company will participate in the TD Cowen 8th Annual Future of the Consumer Conference being held at the Conrad New York Downtown in New York City. Management will host a fireside chat presentation at 1:00 p.m. Eastern Time and hold investor meetings throughout the day. On June 10, 2024, the Company will participate in the Oppenheimer 24th Annual Consumer Growth and E-Commerce Conference being held virtually. Managemen
$68.3 million of Net Revenue+21.0% Comparable Net Revenue: +20.6% Obagi Skincare and +21.5% Milk MakeupAdjusted EBITDA of $11.4 million, up +12.9% vs Q1 2023 WHITE PLAINS, N.Y., May 21, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the quarter ended March 31, 2024 ("Q1 2024 Financials") on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company's investor relations site at http://ir.waldencast.com/. Michel Brousset, Waldencast Founder and CEO, said: "We had a strong start to the year, growing 21.0% in Comparable Net Rev
Canaccord Genuity initiated coverage of Waldencast plc with a rating of Buy and set a new price target of $5.00
Telsey Advisory Group reiterated coverage of Waldencast plc with a rating of Outperform and set a new price target of $8.00 from $10.00 previously
Raymond James downgraded Waldencast plc from Outperform to Mkt Perform
DA Davidson initiated coverage of Waldencast plc with a rating of Buy and set a new price target of $12.00
Raymond James initiated coverage of Waldencast plc with a rating of Outperform and set a new price target of $11.00
Jefferies initiated coverage of Waldencast plc with a rating of Buy and set a new price target of $11.00
Telsey Advisory Group initiated coverage of Waldencast Acquisition Corp. with a rating of Outperform and set a new price target of $13.00
SC 13D/A - Waldencast plc (0001840199) (Subject)
SC 13G - Waldencast plc (0001840199) (Subject)
SC 13G/A - Waldencast plc (0001840199) (Subject)
SC 13D/A - Waldencast plc (0001840199) (Subject)
SC 13D/A - Waldencast plc (0001840199) (Subject)
SC 13D - Waldencast plc (0001840199) (Subject)
SC 13G/A - Waldencast plc (0001840199) (Subject)
SC 13G/A - Waldencast plc (0001840199) (Subject)
SC 13G/A - Waldencast plc (0001840199) (Subject)
SC 13G/A - Waldencast plc (0001840199) (Subject)
U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Friday. Shares of Argan, Inc. (NYSE:AGX) rose sharply during Friday's session after the company reported better-than-expected first-quarter financial results. Argan posted quarterly earnings of 58 cents per share, beating market estimates of 52 cents per share. The company's quarterly sales came in at $157.68 million versus expectations of $134.75 million, according to data from Benzinga Pro. Argan shares climbed 11.1% to $76.78 on Thursday. Here are some other big stocks recording gains in today’s session. Geron Corporation (NASDAQ:GERN) shares climbed 26% to $4.90 as the company reported the FDA approva
DA Davidson analyst Linda Bolton Weiser maintains Waldencast (NASDAQ:WALD) with a Buy and lowers the price target from $15.5 to $6.5.
Telsey Advisory Group analyst Dana Telsey maintains Waldencast (NASDAQ:WALD) with a Outperform and maintains $8 price target.
Shares of James Hardie Industries plc (NYSE:JHX) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results. James Hardie Industries posted adjusted earnings of 40 cents per share, missing market expectations of 42 cents per share. The company's quarterly sales came in at $1.005 billion versus estimates of $1.009 billion, according to data from Benzinga Pro. JP Morgan analyst Al Harvey downgraded James Hardie Industries from Overweight to Neutral. James Hardie Industries shares dipped 14.3% to $31.36 on Tuesday. Here are some other stocks moving in today’s mid-day session. Gainers MGO Global, Inc. (NASDAQ:MGOL) shares j
Fiscal 2024 Outlook: We expect full year Comparable Net Revenues to grow faster than the growth rate seen in the Q1 2024. Adjusted EBITDA Margin for FY2024 is expected to be in the mid-teens, substantially higher than FY 2023 of 11.2%. This will be driven by anticipated improvement of Gross Margin vs. 2023 and dilution of fixed expenses, balanced with efficient investments in sales and marketing growth drivers.
Waldencast (NASDAQ:WALD) reported $68.27 million in sales this quarter. This is a 13.88 percent increase over sales of $59.95 million the same period last year.
U.S. stocks were mostly higher, with the Dow Jones index gaining around 50 points on Tuesday. Shares of XPeng Inc. (NYSE:XPEV) rose sharply during Tuesday's session after the company reported better-than-expected first-quarter results and issued second-quarter guidance. XPeng reported fiscal first-quarter sales growth of 62.3% year-on-year, to 6.55 billion Chinese Yuan ($0.91 billion), beating the analyst consensus estimate of 6.17 billion Chinese Yuan ($0.87 billion). Total revenues declined 49.8% sequentially. Adjusted net loss per ADS of $0.21 beat the analyst consensus loss estimate of $0.27, according to data from Benzinga Pro. XPeng shares jumped 10% to $9.12 on Tuesday. He
Telsey Advisory Group analyst Dana Telsey maintains Waldencast (NASDAQ:WALD) with a Outperform and maintains $8 price target.
Telsey Advisory Group analyst Dana Telsey maintains Waldencast (NASDAQ:WALD) with a Outperform and lowers the price target from $10 to $8.